Forward Industries, Inc. - 10-Q Summary (Q2 Fiscal 2010)
Business Context and Reporting Period
Forward Industries, Inc. designs, markets, and distributes carry solutions (cases, bags, accessories) primarily for handheld electronic devices, including medical monitoring kits (diabetic products), cellular telephones, and bar code scanners. The company serves Original Equipment Manufacturers (OEMs) globally. This report covers the quarterly period ended March 31, 2010 (the "2010 Quarter") and the six-month period ended March 31, 2010 (the "2010 Period").
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2010 | Six Months Ended Mar 31, 2010 |
|---|---|---|
| Net Sales | $4,419,681 | $8,546,453 |
| Gross Profit | $993,743 | $1,917,938 |
| Gross Margin | 22.5% | 22.4% |
| Operating Loss | $(90,957) | $(285,155) |
| Net Loss | $(112,194) | $(299,180) |
| Loss Per Share (Basic/Diluted) | $(0.01) | $(0.04) |
| Cash and Cash Equivalents | $19,673,323 | $19,673,323 |
| Total Debt | $0 | $0 |
| Working Capital | $22,151,449 | $22,151,449 |
Material Changes vs. Prior Period
- Quarter-over-Quarter (Q2 2010 vs. Q2 2009):
- Net Sales: Increased 4% ($163k) to $4.4M, driven by a 13% increase in diabetic product sales, partially offset by a 21% decline in "Other Products" (primarily cell phone accessories).
- Gross Profit: Improved 50% to $994k due to higher sales volume and a 5% reduction in cost of goods sold (lower personnel costs in Hong Kong, better product mix, and reduced freight costs).
- Operating Expenses: Decreased 21% to $1.1M, primarily due to reduced selling personnel costs and travel expenses.
- Net Loss: Narrowed significantly to $112k from a loss of $1.1M in the prior year quarter.
- Year-to-Date (Six Months 2010 vs. Six Months 2009):
- Net Sales: Decreased 11% ($1.0M) to $8.5M due to declines in both diabetic products and other products.
- Net Loss: Improved to $299k from a loss of $1.3M in the prior year period, aided by lower operating expenses and reduced income tax provisions.
Outlook, Risks, and Management Commentary
- Market Conditions: Management notes a challenging environment with high customer concentration. While there is a modest increase in orders from major diabetic customers, the sustainability of this improvement is uncertain.
- Strategy: The company is pursuing diversification through acquisitions or investments to reduce reliance on diabetic products and cell phone accessories. Marketing efforts to expand the customer base are showing preliminary success with small initial orders from new customers.
- Liquidity: The company maintains strong liquidity with approximately $19.7M in cash and no debt. A significant portion of cash is held in a Swiss subsidiary and considered permanently invested.
- Risks:
- Customer Concentration: Sales are highly concentrated among a few large OEMs, making revenue volatile.
- Product Concentration: Diabetic product sales represented 80% of total net sales in the 2010 Quarter.
- Contingencies: A Swiss subsidiary has a bank letter of guarantee up to approximately $101,000 (€75,000) for potential VAT liabilities in the Netherlands. No liability has been incurred as of March 31, 2010.
- Tax Position: The company has established a full valuation allowance against its deferred tax assets ($677k) due to uncertainty regarding future taxable income.
Investor Verification Checklist
- Verify the sustainability of the recent order increase from major diabetic customers versus historical volatility.
- Monitor progress on the acquisition strategy intended to diversify revenue streams away from diabetic products.
- Review the status of the $101,000 contingent liability regarding the Netherlands VAT guarantee.
- Assess the impact of the full valuation allowance on deferred tax assets on future earnings if profitability improves.
- Confirm the trend in "Other Products" sales, specifically the decline in cell phone accessory revenue.